ASCO 2020: Phase III Trial Aims to Identify Role of Linrodostat Mesylate in Advanced Bladder Cancer
The global study will compare standard chemotherapy to standard chemotherapy plus linrodostat, with or without nivolumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.